dapsone has been researched along with Scleritis in 5 studies
Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyoderma gangrenosum is a rare autoimmune disorder that can affect the eye." | 5.34 | Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy. ( Baltatzis, S; Foster, CS; Teasley, LA, 2007) |
| "Pyoderma gangrenosum is a rare autoimmune disorder that can affect the eye." | 1.34 | Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy. ( Baltatzis, S; Foster, CS; Teasley, LA, 2007) |
| "Ocular manifestations are uncommon in Sweet's syndrome but it is important to diagnose and treat them." | 1.34 | Nodular scleritis and Sweet's syndrome. ( Loh, RS; Su, DH; Wong, MH, 2007) |
| "Dapsone, which has been reported to be effective in the treatment of relapsing polychondritis, did not control the destructive scleral inflammation in six (75%) of eight patients; two (50%) of four patients with diffuse anterior scleritis were controlled with this drug." | 1.28 | Scleritis in relapsing polychondritis. Response to therapy. ( Foster, CS; Hoang-Xaun, T; Rice, BA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inamadar, AC | 1 |
| Anitha, B | 1 |
| Mitamura, Y | 1 |
| Fujiwara, O | 1 |
| Miyanishi, K | 1 |
| Sato, H | 1 |
| Saga, K | 1 |
| Ohtsuka, K | 1 |
| Teasley, LA | 1 |
| Foster, CS | 2 |
| Baltatzis, S | 1 |
| Wong, MH | 1 |
| Su, DH | 1 |
| Loh, RS | 1 |
| Hoang-Xaun, T | 1 |
| Rice, BA | 1 |
5 other studies available for dapsone and Scleritis
| Article | Year |
|---|---|
HIV-seropositive patient with Sweet's syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy.
Topics: Administration, Oral; Adult; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule | 2008 |
Nodular scleritis and panuveitis with erythema elevatum diutinum.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Therapy, Combination; Erythema; Female | 2004 |
Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Face; Female; Follow-Up Studies; Hu | 2007 |
Nodular scleritis and Sweet's syndrome.
Topics: Administration, Oral; Adult; Colchicine; Dapsone; Dexamethasone; Drug Therapy, Combination; Female; | 2007 |
Scleritis in relapsing polychondritis. Response to therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; | 1990 |